Response to US review rules on patent subject matter of traditional Chinese medicine compositions / 中国中药杂志
China Journal of Chinese Materia Medica
;
(24): 627-630, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-771691
ABSTRACT
The United States Patent and Trademark Office(USPTO) issued Interim Guidance on Patent Subject Matter Eligibility on December 16, 2014, bringing certain effects to the review rules on patent application of Chinese medicine compositions. Based on the Interim Guidance, cases analysis was used in this paper to analyze the patent subject matter issues of traditional Chinese medicine compositions in the United States. The researches have shown that the application documents should be properly written in the United States when the patent for Chinese medicine compositions is applied, which can improve the probability of authorization.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Patentes como Asunto
/
Estándares de Referencia
/
Investigación
/
Estados Unidos
/
Medicamentos Herbarios Chinos
/
Química
/
Medicina Tradicional China
Tipo de estudio:
Estudio diagnóstico
País/Región como asunto:
America del Norte
Idioma:
Chino
Revista:
China Journal of Chinese Materia Medica
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS